Skip to main content
VCbacked
Log inGet Started

Flightpath Biosciences

Berkeley, United States

Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.

$8.1M raised
Feb 2023
Series A
BiotechnologyHealth CareLife ScienceTherapeutics

Top Investors

Michigan RiseAnn Arbor SPARKIllumina Accelerator

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Flightpath Biosciences

How much funding has Flightpath Biosciences raised?
Flightpath Biosciences has raised $8.1M in total funding. The most recent round was Series A. The last funding was announced in February 2023.
Who are Flightpath Biosciences's investors?
Flightpath Biosciences's investors include Michigan Rise, Ann Arbor SPARK, Illumina Accelerator.
Where is Flightpath Biosciences headquartered?
Flightpath Biosciences is headquartered in Berkeley, United States.
What does Flightpath Biosciences do?
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
What stage is Flightpath Biosciences at?
Flightpath Biosciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Flightpath Biosciences — Funding & Investors." VCBacked, February 15, 2023, https://www.vcbacked.co/company/flightpath-biosciences. Accessed June 5, 2026.
APA
VCBacked. (2023). Flightpath Biosciences — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/flightpath-biosciences
Wikipedia (cite web)
{{cite web |title=Flightpath Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/flightpath-biosciences |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong